Actinium Pharmaceuticals, Inc. (ATNM) vs Serina Therapeutics, Inc. (SER)
- Actinium Pharmaceuticals, Inc. ATNM 1.42 +9.23%
- Serina Therapeutics, Inc. SER 1.40 −15.15%
Actinium Pharmaceuticals, Inc. and Serina Therapeutics, Inc. are both Biotechnology companies. Actinium Pharmaceuticals, Inc. and Serina Therapeutics, Inc. are of similar size ($41.9M and $40.9M). Serina Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Actinium Pharmaceuticals, Inc. trades at 3.9×. Actinium Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 2,731.2% against −94.2%. Actinium Pharmaceuticals, Inc. has the higher net margin (32.2% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Actinium Pharmaceuticals, Inc. leads on 11 and Serina Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | ATNM | SER | Biotechnology median |
|---|---|---|---|
| Gross margin | 98.71% | 100.00% | 68.51% |
| Operating margin | 27.20% | 0.00% | 0.00% |
| Net margin | 32.18% | 0.00% | 0.00% |
| Free cash flow margin | (66.16%) | 0.00% | 0.00% |
| Return on equity | 45.86% | (306.22%) | (51.96%) |
| Return on assets | 21.92% | (136.00%) | (46.06%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack